NDC 58980-780

Venelex

Castor Oil And Balsam, Peru

Venelex is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Stratus Pharamceuticals, Inc. The primary component is Castor Oil; Balsam, Peru.

Product ID58980-780_ae718f2b-8848-4f0c-b556-1561a3524c8f
NDC58980-780
Product TypeHuman Prescription Drug
Proprietary NameVenelex
Generic NameCastor Oil And Balsam, Peru
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2009-11-29
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameStratus Pharamceuticals, Inc
Substance NameCASTOR OIL; BALSAM, PERU
Active Ingredient Strength788 mg/g; mg/g
Pharm ClassesStandardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 58980-780-21

1 TUBE in 1 BOX (58980-780-21) > 60 g in 1 TUBE
Marketing Start Date2009-11-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58980-780-21 [58980078021]

VENELEX OINTMENT
Marketing CategoryExempt device
Application NumberNAD
Product TypeMEDICAL DEVICE
Billing UnitGM
Marketing Start Date2017-09-15
Inactivation Date2019-10-21

NDC 58980-780-11 [58980078011]

VENELEX OINTMENT
Marketing CategoryExempt device
Application NumberNAD
Product TypeMEDICAL DEVICE
Billing UnitGM
Marketing Start Date2015-06-11

NDC 58980-780-50 [58980078050]

VENELEX OINTMENT
Marketing CategoryExempt device
Application NumberNAD
Product TypeMEDICAL DEVICE
Billing UnitGM
Marketing Start Date2015-06-11

Drug Details

Active Ingredients

IngredientStrength
CASTOR OIL788 mg/g

OpenFDA Data

SPL SET ID:13291e03-6f75-403b-afc4-c44a10ca0083
Manufacturer
UNII

Pharmacological Class

  • Standardized Chemical Allergen [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Allergens [CS]

Trademark Results [Venelex]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VENELEX
VENELEX
98501920 not registered Live/Pending
Stratus Pharmaceuticals, Inc.
2024-04-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.